Gene therapy is poised to change the future of human health as we know it. These transformative therapies have the potential to fundamentally and profoundly reshape the way thousands of diseases are treated with long-lasting – potentially life-long – benefit for patients. For all the excitement, significant challenges threaten to prevent patients from accessing these transformative therapies as the science has advanced more quickly than our healthcare system.
By bringing together expert stakeholders from across the healthcare system, the Institute for Gene Therapies or IGT, advocates for modernized policies that encourage transformative gene therapies, promotes patient access and codifies transparent reimbursement practices.
Our advisory council members are crucial to our efforts:
Together, we are catalyzing this important conversation to help ensure patients are given every opportunity to thrive.